July 26 2022 Healthcare & Life Sciences Limited to Report Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 and Provide Corporate Update June 13 2022 Healthcare & Life Sciences Limited Appoints Recognized Industry Leader John W. Sharkey, PhD as Vice President, Business Development June 07 2022 Healthcare & Life Sciences Limited to Present at BIO International Convention 2022 May 25 2022 Healthcare & Life Sciences Limited Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules May 24 2022 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent in China May 04 2022 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences April 27 2022 Healthcare & Life Sciences Limited Reports 2022 First Quarter Financial Results and Provides Corporate Update April 26 2022 Healthcare & Life Sciences Limited Announces Issuance of Malaria Vaccine Patent April 19 2022 Healthcare & Life Sciences Limited to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate Update April 12 2022 Healthcare & Life Sciences Limited to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress March 22 2022 Healthcare & Life Sciences Limited Announces Issuance of Cancer Vaccine Patent March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022 March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
June 13 2022 Healthcare & Life Sciences Limited Appoints Recognized Industry Leader John W. Sharkey, PhD as Vice President, Business Development June 07 2022 Healthcare & Life Sciences Limited to Present at BIO International Convention 2022 May 25 2022 Healthcare & Life Sciences Limited Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules May 24 2022 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent in China May 04 2022 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences April 27 2022 Healthcare & Life Sciences Limited Reports 2022 First Quarter Financial Results and Provides Corporate Update April 26 2022 Healthcare & Life Sciences Limited Announces Issuance of Malaria Vaccine Patent April 19 2022 Healthcare & Life Sciences Limited to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate Update April 12 2022 Healthcare & Life Sciences Limited to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress March 22 2022 Healthcare & Life Sciences Limited Announces Issuance of Cancer Vaccine Patent March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022 March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
June 07 2022 Healthcare & Life Sciences Limited to Present at BIO International Convention 2022 May 25 2022 Healthcare & Life Sciences Limited Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules May 24 2022 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent in China May 04 2022 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences April 27 2022 Healthcare & Life Sciences Limited Reports 2022 First Quarter Financial Results and Provides Corporate Update April 26 2022 Healthcare & Life Sciences Limited Announces Issuance of Malaria Vaccine Patent April 19 2022 Healthcare & Life Sciences Limited to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate Update April 12 2022 Healthcare & Life Sciences Limited to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress March 22 2022 Healthcare & Life Sciences Limited Announces Issuance of Cancer Vaccine Patent March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022 March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
May 25 2022 Healthcare & Life Sciences Limited Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules May 24 2022 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent in China May 04 2022 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences April 27 2022 Healthcare & Life Sciences Limited Reports 2022 First Quarter Financial Results and Provides Corporate Update April 26 2022 Healthcare & Life Sciences Limited Announces Issuance of Malaria Vaccine Patent April 19 2022 Healthcare & Life Sciences Limited to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate Update April 12 2022 Healthcare & Life Sciences Limited to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress March 22 2022 Healthcare & Life Sciences Limited Announces Issuance of Cancer Vaccine Patent March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022 March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
May 24 2022 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent in China May 04 2022 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences April 27 2022 Healthcare & Life Sciences Limited Reports 2022 First Quarter Financial Results and Provides Corporate Update April 26 2022 Healthcare & Life Sciences Limited Announces Issuance of Malaria Vaccine Patent April 19 2022 Healthcare & Life Sciences Limited to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate Update April 12 2022 Healthcare & Life Sciences Limited to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress March 22 2022 Healthcare & Life Sciences Limited Announces Issuance of Cancer Vaccine Patent March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022 March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
May 04 2022 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences April 27 2022 Healthcare & Life Sciences Limited Reports 2022 First Quarter Financial Results and Provides Corporate Update April 26 2022 Healthcare & Life Sciences Limited Announces Issuance of Malaria Vaccine Patent April 19 2022 Healthcare & Life Sciences Limited to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate Update April 12 2022 Healthcare & Life Sciences Limited to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress March 22 2022 Healthcare & Life Sciences Limited Announces Issuance of Cancer Vaccine Patent March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022 March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
April 27 2022 Healthcare & Life Sciences Limited Reports 2022 First Quarter Financial Results and Provides Corporate Update April 26 2022 Healthcare & Life Sciences Limited Announces Issuance of Malaria Vaccine Patent April 19 2022 Healthcare & Life Sciences Limited to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate Update April 12 2022 Healthcare & Life Sciences Limited to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress March 22 2022 Healthcare & Life Sciences Limited Announces Issuance of Cancer Vaccine Patent March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022 March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
April 26 2022 Healthcare & Life Sciences Limited Announces Issuance of Malaria Vaccine Patent April 19 2022 Healthcare & Life Sciences Limited to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate Update April 12 2022 Healthcare & Life Sciences Limited to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress March 22 2022 Healthcare & Life Sciences Limited Announces Issuance of Cancer Vaccine Patent March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022 March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
April 19 2022 Healthcare & Life Sciences Limited to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate Update April 12 2022 Healthcare & Life Sciences Limited to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress March 22 2022 Healthcare & Life Sciences Limited Announces Issuance of Cancer Vaccine Patent March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022 March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
April 12 2022 Healthcare & Life Sciences Limited to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress March 22 2022 Healthcare & Life Sciences Limited Announces Issuance of Cancer Vaccine Patent March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022 March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 22 2022 Healthcare & Life Sciences Limited Announces Issuance of Cancer Vaccine Patent March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022 March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 21 2022 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022 March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 16 2022 Healthcare & Life Sciences Limited to Participate in Maxim Group’s 2022 Virtual Growth Conference March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 14 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 10 2022 Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2 March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 09 2022 Healthcare & Life Sciences Limited Reports 2021 Year-End Financial Results And Provides Corporate Update March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 07 2022 Healthcare & Life Sciences Limited Announces Key Staff Appointments February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
February 23 2022 Healthcare & Life Sciences Limited to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
February 22 2022 Healthcare & Life Sciences Limited CEO Selected as a Recipient of the 2022 Georgia Titan 100 February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
February 08 2022 Healthcare & Life Sciences Limited to Present at the 2022 BIO CEO & Investor Digital Conference January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
January 20 2022 Healthcare & Life Sciences Limited Announces Closing of $10 Million Private Placement January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
January 14 2022 Healthcare & Life Sciences Limited Announces $10 Million Private Placement January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
January 13 2022 Healthcare & Life Sciences Limited Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical Trial January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
January 11 2022 Healthcare & Life Sciences Limited Appoints Dr. Kelly McKee as Chief Medical Officer January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
January 05 2022 Healthcare & Life Sciences Limited to Participate in Upcoming Life Sciences Investor Conferences January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
January 04 2022 Healthcare & Life Sciences Limited Issues Shareholder Update Letter December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
December 15 2021 Healthcare & Life Sciences Limited Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
December 13 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Malaria Vaccine Patent December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
December 03 2021 Healthcare & Life Sciences Limited Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
December 01 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
November 16 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the Vaccine World Asia Congress November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
November 16 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Cancer Vaccine Patent November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
November 15 2021 Healthcare & Life Sciences Limited Announces Upcoming Presentations at Scientific Conferences November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
November 11 2021 Healthcare & Life Sciences Limited Reports 2021 Third Quarter Financial Results and Provides Corporate Update November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
November 09 2021 Healthcare & Life Sciences Limited and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
November 04 2021 Healthcare & Life Sciences Limited to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
October 18 2021 Healthcare & Life Sciences Limited Chief Scientific Officer to Participate in World Vaccine Congress Europe October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
October 14 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Ebola Vaccine Patent September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
September 28 2021 Healthcare & Life Sciences Limited Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
September 07 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
August 19 2021 Healthcare & Life Sciences Limited Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
August 12 2021 Healthcare & Life Sciences Limited to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
August 11 2021 Healthcare & Life Sciences Limited Reports 2021 Second Quarter Financial Results and Provides Corporate Update August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
August 04 2021 Healthcare & Life Sciences Limited to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
July 22 2021 Healthcare & Life Sciences Limited Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
July 02 2021 Healthcare & Life Sciences Limited Announces Issuance of Hepatitis B Vaccine Patent June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
June 10 2021 Healthcare & Life Sciences Limited to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
June 07 2021 Healthcare & Life Sciences Limited to Present at 2021 BIO Digital May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
May 11 2021 Healthcare & Life Sciences Limited Labs, Inc. Invites You to Join Us at the Q2 Virtual Investor Summit May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
May 06 2021 Healthcare & Life Sciences Limited Reports 2021 First Quarter Financial Results and Provides Corporate Update May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
May 06 2021 Healthcare & Life Sciences Limited to Present to Investors at the Benzinga Global Small Cap Conference on May 13, 2021 April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
April 26 2021 Healthcare & Life Sciences Limited to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
April 01 2021 Healthcare & Life Sciences Limited Receives Notice of Allowance for Hepatitis B Vaccine Patent March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 23 2021 Healthcare & Life Sciences Limited Reports 2020 Year-End Financial Results And Provides Corporate Update March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 17 2021 Healthcare & Life Sciences Limited to Participate in Benzinga Biotech Small Cap Conference March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 15 2021 Healthcare & Life Sciences Limited to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 10 2021 Healthcare & Life Sciences Limited to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 04 2021 Healthcare & Life Sciences Limited Expands and Strengthens Intellectual Property Portfolio March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 03 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Global Life Sciences Conference March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 01 2021 Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring Healthcare & Life Sciences Limited’s CEO & CFO On March 3, 2021 February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
February 11 2021 Healthcare & Life Sciences Limited Announces Closing of $10.3 Million Bought Deal Offering February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
February 09 2021 Healthcare & Life Sciences Limited Announces Pricing of $9.0 Million Bought Deal Offering January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
January 11 2021 Healthcare & Life Sciences Limited Awarded NIH Grant to Advance COVID-19 Vaccine Development January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
January 05 2021 Healthcare & Life Sciences Limited to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
November 30 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
November 05 2020 Healthcare & Life Sciences Limited Reports 2020 Third Quarter Financial Results and Provides Corporate Update October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
October 30 2020 Healthcare & Life Sciences Limited to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
October 28 2020 Healthcare & Life Sciences Limited CEO David Dodd to Participate in Virtual Webinar hosted by Outsourced Pharma October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
October 26 2020 Healthcare & Life Sciences Limited Announces License Agreement with NIH to Support COVID-19 Vaccine Development September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
September 29 2020 Healthcare & Life Sciences Limited Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
September 25 2020 Healthcare & Life Sciences Limited Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
September 15 2020 Healthcare & Life Sciences Limited to Participate in World Vaccine Congress Session Addressing the Global Need for an HIV Vaccine September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
September 03 2020 Healthcare & Life Sciences Limited Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Marburg Virus Showing 100% Protection August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
August 26 2020 Healthcare & Life Sciences Limited Appoints Mark J. Newman, Ph.D. Chief Scientific Officer August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
August 24 2020 Healthcare & Life Sciences Limited Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
August 13 2020 Healthcare & Life Sciences Limited Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
August 10 2020 Healthcare & Life Sciences Limited Reports 2020 Second Quarter Financial Results and Provides Corporate Update June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
June 29 2020 Healthcare & Life Sciences Limited Announces Closing of $1 Million Private Placement June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
June 29 2020 Healthcare & Life Sciences Limited to Participate in International Webinar Focused on the State of COVID-19 Vaccines June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
June 10 2020 Healthcare & Life Sciences Limited to Present COVID-19 Vaccine Program at National Foundation for Infectious Diseases Annual Conference on Vaccinology Research June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
June 04 2020 Healthcare & Life Sciences Limited Labs, Inc. Announces Approval for Trading on OTCQB Venture Market May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
May 06 2020 Healthcare & Life Sciences Limited Reports 2020 First Quarter Financial Results and Provides Corporate Update April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
April 30 2020 Healthcare & Life Sciences Limited and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 30 2020 Healthcare & Life Sciences Limited Applauds and Comments on Passage of $2 Trillion CARES Act March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 25 2020 Healthcare & Life Sciences Limited Reports 2019 Year-End Financial Results And Provides Corporate Update March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 18 2020 Healthcare & Life Sciences Limited Progresses in Coronavirus (COVID-19) Vaccine Development Program March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 04 2020 Healthcare & Life Sciences Limited Provides Update on Coronavirus (COVID-19) Vaccine Development Program February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
February 27 2020 Healthcare & Life Sciences Limited to Present at World Immunotherapy Congress 2020 February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
February 06 2020 Healthcare & Life Sciences Limited Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
January 27 2020 Healthcare & Life Sciences Limited and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
January 23 2020 Healthcare & Life Sciences Limited Announces Reverse Stock Split December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
December 03 2019 Healthcare & Life Sciences Limited to Present at World Vaccine & Immunotherapy Conference December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
December 02 2019 Healthcare & Life Sciences Limited Observes 2019 World AIDS Day November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
November 14 2019 Healthcare & Life Sciences Limited to Present at Vaccines R&D Conference November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
November 13 2019 Healthcare & Life Sciences Limited Vaccine Selected to Participate in Development of Potential HIV Functional Cure November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
November 11 2019 Healthcare & Life Sciences Limited Reports 2019 Third Quarter Financial Results and Provides Corporate Update October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
October 24 2019 Healthcare & Life Sciences Limited Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
October 15 2019 Healthcare & Life Sciences Limited Presenting at Upcoming October European Scientific Conferences October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
October 03 2019 Healthcare & Life Sciences Limited CEO Q&A: Answering Shareholder's Questions October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
October 01 2019 Healthcare & Life Sciences Limited CEO Comments on Recent Changes in Capital Structure September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
September 09 2019 Leveraging Healthcare & Life Sciences Limited's Vaccine Expertise To Take On Cancer September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
September 04 2019 Healthcare & Life Sciences Limited Announces Publication of Lassa Fever Vaccine Study Results August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
August 14 2019 Healthcare & Life Sciences Limited Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
August 02 2019 Healthcare & Life Sciences Limited Issues Shareholder Update Letter July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
July 30 2019 Healthcare & Life Sciences Limited Addresses WHO Declaration of Ebola Outbreak as Global Public Health Emergency July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
July 29 2019 Healthcare & Life Sciences Limited Announces 100% Protection Data from Marburg Virus Vaccine Study July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
July 24 2019 Healthcare & Life Sciences Limited Presents HIV Vaccine Study Data July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
July 16 2019 Healthcare & Life Sciences Limited Announces Upcoming Presentation of Lassa Fever Vaccine Data May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
May 22 2019 Healthcare & Life Sciences Limited to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019 May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
May 16 2019 Healthcare & Life Sciences Limited Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11 May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
May 15 2019 Healthcare & Life Sciences Limited to Present Unique Technology at New York Academy of Sciences Vaccine Conference May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
May 14 2019 Healthcare & Life Sciences Limited Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
May 03 2019 Healthcare & Life Sciences Limited Announces Reverse Stock Split April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
April 24 2019 Healthcare & Life Sciences Limited Recognizes World Malaria Day 2019 March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 27 2019 Healthcare & Life Sciences Limited Reports 2018 Year-End Financial Results March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 19 2019 Healthcare & Life Sciences Limited Ebola Vaccine Study Published in the Atlas of Science March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 12 2019 Healthcare & Life Sciences Limited Selected as Finalist for Vaccine Industry Excellence Awards March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 11 2019 Healthcare & Life Sciences Limited Provides Product Development and Corporate Update March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
March 04 2019 Healthcare & Life Sciences Limited and Leidos Expand Collaboration to Malaria Vaccines February 14 2019 Healthcare & Life Sciences Limited Issues Open Letter to HHS Secretary Alex Azar
